(LYKO-A) Lyko - Ratings and Ratios
Shampoo,Haircolor,Skincare,Makeup,Styling
LYKO-A EPS (Earnings per Share)
LYKO-A Revenue
Description: LYKO-A Lyko
Lyko Group A, traded as LYKO-A, is a Swedish company operating in the Personal Care Products sub-industry. The companys stock performance is influenced by its market capitalization of 2158.71M SEK, indicating a mid-to-large cap stock in the Swedish market.
The stocks valuation metrics, such as a P/E ratio of 33.98 and a forward P/E of 29.94, suggest that investors are pricing in future growth expectations. The Return on Equity (RoE) of 13.76% indicates a relatively healthy profitability level, although it may be considered moderate compared to industry peers or broader market benchmarks.
Key economic drivers for Lyko Group A likely include consumer spending trends in personal care products, competition within the Swedish and broader Nordic markets, and the companys ability to innovate and maintain market share. The personal care products industry is generally less cyclical than other consumer goods sectors, but it is still subject to economic downturns and changes in consumer preferences.
To evaluate the stocks potential, one should monitor KPIs such as sales growth, gross margin development, and operating expenses as a percentage of sales. Additionally, tracking the companys ability to generate cash from operations and its capital allocation strategies will be crucial. The stocks beta of 1.423 indicates a higher volatility compared to the overall market, suggesting that investors should be prepared for potential price swings.
From a trading perspective, analyzing the stocks price action in relation to its moving averages (SMA20, SMA50, SMA200) and other technical indicators can provide insights into market sentiment and potential trading opportunities. The Average True Range (ATR) of 5.40, or 3.98%, indicates the stocks recent price volatility, which can inform risk management strategies.
LYKO-A Stock Overview
| Market Cap in USD | 229m |
| Sub-Industry | Personal Care Products |
| IPO / Inception |
LYKO-A Stock Ratings
| Growth Rating | -19.0% |
| Fundamental | 61.6% |
| Dividend Rating | 0.18% |
| Return 12m vs S&P 500 | 5.22% |
| Analyst Rating | - |
LYKO-A Dividends
Currently no dividends paidLYKO-A Growth Ratios
| Growth Correlation 3m | 76.9% |
| Growth Correlation 12m | 58.5% |
| Growth Correlation 5y | -87.3% |
| CAGR 5y | -19.11% |
| CAGR/Max DD 5y | -0.24 |
| Sharpe Ratio 12m | -0.68 |
| Alpha | 12.24 |
| Beta | 0.436 |
| Volatility | 34.36% |
| Current Volume | 2k |
| Average Volume 20d | 6.7k |
| Stop Loss | 135.4 (-3.8%) |
| Signal | -0.75 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (63.4m TTM) > 0 and > 6% of Revenue (6% = 222.9m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 0.68pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -8.85% (prev -8.31%; Δ -0.54pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 287.5m > Net Income 63.4m (YES >=105%, WARN >=100%) |
| Net Debt (1.12b) to EBITDA (323.3m) ratio: 3.47 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.70 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (15.3m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 34.06% (prev 11.35%; Δ 22.71pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 162.1% (prev 156.0%; Δ 6.14pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.84 (EBITDA TTM 323.3m / Interest Expense TTM 80.7m) >= 6 (WARN >= 3) |
Altman Z'' -0.25
| (A) -0.14 = (Total Current Assets 764.5m - Total Current Liabilities 1.09b) / Total Assets 2.43b |
| (B) 0.04 = Retained Earnings (Balance) 102.5m / Total Assets 2.43b |
| (C) 0.06 = EBIT TTM 148.3m / Avg Total Assets 2.29b |
| (D) 0.06 = Book Value of Equity 112.3m / Total Liabilities 1.95b |
| Total Rating: -0.25 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.58
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 0.70% = 0.35 |
| 3. FCF Margin 0.52% = 0.13 |
| 4. Debt/Equity 1.43 = 1.56 |
| 5. Debt/Ebitda 2.15 = -0.30 |
| 6. ROIC - WACC 2.57% = 3.22 |
| 7. RoE 13.78% = 1.15 |
| 8. Rev. Trend 79.35% = 3.97 |
| 9. Rev. CAGR 20.63% = 2.50 |
| 10. EPS Trend -0.76% = -0.02 |
| 11. EPS CAGR -3.81% = -0.48 |
What is the price of LYKO-A shares?
Over the past week, the price has changed by -0.14%, over one month by +5.39%, over three months by +19.32% and over the past year by +23.08%.
Is Lyko a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LYKO-A is around 126.33 SEK . This means that LYKO-A is currently overvalued and has a potential downside of -10.28%.
Is LYKO-A a buy, sell or hold?
What are the forecasts/targets for the LYKO-A price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 151.7 | 7.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 137.9 | -2.1% |
LYKO-A Fundamental Data Overview
Market Cap SEK = 2.18b (2.18b SEK * 1.0 SEK.SEK)
CCE Cash And Equivalents = 106.4m SEK (Cash And Short Term Investments, last quarter)
P/E Trailing = 34.3961
P/E Forward = 30.2115
P/S = 0.5859
P/B = 4.4676
Beta = 1.388
Revenue TTM = 3.72b SEK
EBIT TTM = 148.3m SEK
EBITDA TTM = 323.3m SEK
Long Term Debt = 297.4m SEK (from longTermDebt, last quarter)
Short Term Debt = 398.0m SEK (from shortTermDebt, last quarter)
Debt = 695.4m SEK (Calculated: Short Term 398.0m + Long Term 297.4m)
Net Debt = 1.12b SEK (from netDebt column, last quarter)
Enterprise Value = 2.77b SEK (2.18b + Debt 695.4m - CCE 106.4m)
Interest Coverage Ratio = 1.84 (Ebit TTM 148.3m / Interest Expense TTM 80.7m)
FCF Yield = 0.70% (FCF TTM 19.4m / Enterprise Value 2.77b)
FCF Margin = 0.52% (FCF TTM 19.4m / Revenue TTM 3.72b)
Net Margin = 1.71% (Net Income TTM 63.4m / Revenue TTM 3.72b)
Gross Margin = 34.06% ((Revenue TTM 3.72b - Cost of Revenue TTM 2.45b) / Revenue TTM)
Tobins Q-Ratio = 24.66 (Enterprise Value 2.77b / Book Value Of Equity 112.3m)
Interest Expense / Debt = 2.55% (Interest Expense 17.7m / Debt 695.4m)
Taxrate = 44.15% (from yearly Income Tax Expense: 16.6m / 37.6m)
NOPAT = 82.8m (EBIT 148.3m * (1 - 44.15%))
Current Ratio = 0.70 (Total Current Assets 764.5m / Total Current Liabilities 1.09b)
Debt / Equity = 1.43 (Debt 695.4m / last Quarter total Stockholder Equity 487.3m)
Debt / EBITDA = 2.15 (Net Debt 1.12b / EBITDA 323.3m)
Debt / FCF = 35.85 (Debt 695.4m / FCF TTM 19.4m)
Total Stockholder Equity = 460.2m (last 4 quarters mean)
RoA = 2.61% (Net Income 63.4m, Total Assets 2.43b )
RoE = 13.78% (Net Income TTM 63.4m / Total Stockholder Equity 460.2m)
RoCE = 19.58% (Ebit 148.3m / (Equity 460.2m + L.T.Debt 297.4m))
RoIC = 8.69% (NOPAT 82.8m / Invested Capital 952.7m)
WACC = 6.12% (E(2.18b)/V(2.88b) * Re(7.62%)) + (D(695.4m)/V(2.88b) * Rd(2.55%) * (1-Tc(0.44)))
Shares Correlation 5-Years: 0.0 | Cagr: 0.0%
Discount Rate = 7.62% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈12.7m ; Y1≈8.33m ; Y5≈3.81m
Fair Price DCF = 4.89 (DCF Value 74.8m / Shares Outstanding 15.3m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 79.35 | Revenue CAGR: 20.63%
Rev Growth-of-Growth: -9.16
EPS Correlation: -0.76 | EPS CAGR: -3.81%
EPS Growth-of-Growth: 179.3